Claude Fable 5.1
5.0 out of 5 stars
(1 Rating)
Claude Fable 5.1 is Anthropic’s advanced AI model for coding, knowledge work, research, and long-running agentic tasks. It is designed to improve on Claude Fable 5 with stronger performance across software engineering, scientific research, multidisciplinary reasoning, computer use, business workflows, and complex problem solving. The model can handle extended multi-step work, verify its own results, diagnose difficult software issues, and operate effectively across tool-heavy workflows. Anthropic also reduced cache-read pricing for Fable 5.1, lowering typical usage costs compared with Fable 5 and creating larger savings for highly agentic workloads. Fable 5.1 includes updated safeguards intended to reduce false positives while allowing more legitimate cybersecurity tasks such as vulnerability discovery for defensive purposes. The model is available through Claude products, the Claude API, Amazon Web Services, Google Cloud, and Microsoft Azure.
Learn more about Claude Fable 5.1
BenchSci
BenchSci is an AI-powered platform advancing preclinical drug discovery through intelligent, evidence-driven research. Its agentic research environment, EMET, unifies data, models, software, and scientific reasoning in a single workspace, helping scientists overcome the challenges of a fragmented research landscape. At its core, EMET features an AI co-scientist working alongside specialized agents for target identification, risk assessment, biomarker discovery, omics, and experimental design. These agents draw on BenchSci’s biological knowledge graph, 16 million closed-access papers, and hundreds of curated data sources to support research from disease hypothesis generation through target validation, safety assessment, and ADME/PK. Every insight is traceable to its source, promoting transparency and scientific rigor. With a model-agnostic design, EMET allows teams to choose the AI models that best suit their needs. Since BenchSci does not develop its own drugs, customers retain full ow
Learn more about BenchSci
FutureHouse
FutureHouse is a nonprofit AI research lab focused on automating scientific discovery in biology and other complex sciences. FutureHouse features superintelligent AI agents designed to assist scientists in accelerating research processes. It is optimized for retrieving and summarizing information from scientific literature, achieving state-of-the-art performance on benchmarks like RAG-QA Arena's science benchmark. It employs an agentic approach, allowing for iterative query expansion, LLM re-ranking, contextual summarization, and document citation traversal to enhance retrieval accuracy. FutureHouse also offers a framework for training language agents on challenging scientific tasks, enabling agents to perform tasks such as protein engineering, literature summarization, and molecular cloning. Their LAB-Bench benchmark evaluates language models on biology research tasks, including information extraction, database retrieval, etc.
Learn more about FutureHouse
GPT-Rosalind
GPT-Rosalind is a purpose-built frontier reasoning model developed by OpenAI to accelerate scientific research across biology, drug discovery, and translational medicine. It is designed specifically for life sciences workflows, where researchers must navigate large volumes of literature, experimental data, and specialized databases to generate and validate new ideas. It combines deep domain understanding in areas such as chemistry, genomics, protein engineering, and disease biology with advanced tool-use capabilities, allowing it to interact with scientific databases, analyze experimental outputs, and support complex, multi-step reasoning tasks. It can assist with evidence synthesis, hypothesis generation, literature review, sequence interpretation, and experimental planning, helping scientists move faster from raw data to actionable insights. GPT-Rosalind transforms complex, time-intensive research processes into more efficient AI-assisted workflows.
Learn more about GPT-Rosalind